Delivery Order SPE2DB22D3102-SPE2DB25FK9CU

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of 4564338112 methylphenidate extended-release (ER) 30mg capsules. The contract is a delivery order with a firm fixed price of $1,469.57 and an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,706,514 units of methylphenidate extended-release 20mg capsules, with a ceiling value of $1,483.93. The contract is a firm fixed-price delivery order with a period of performance through March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of 4,565,331,287 units of Methylphenidate Extended-Release 54 mg tablets. The contract has a firm fixed price of $2,004.23 and an ultimate completion date of August 5, 2024. This is a delivery order contract without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide these medications to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,822,213 units of methylphenidate extended-release capsules, 10 mg, in lots of 100. The contract has a firm fixed price of $4,606.60 and a completion date of April 8, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award is for the delivery of 4,564,730,093 units of methylphenidate LA 20 mg capsules in bottles of 100 to the Defense Logistics Agency (DLA). The $1,281.18 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division on May 28, 2024 with a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award is for the delivery of 4,564,084,308 tablets of methylphenidate extended-release 36 mg to the Defense Logistics Agency (DLA) Troop Support Medical program, which supports medical treatment facilities for the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, on March 26, 2024 as a firm fixed price delivery order worth $1,602.48. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 4,564,327,549 methylphenidate extended-release 27 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,356.92 and a completion date of April 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This is a $1,135.20 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,404,218 units of 27 mg methylphenidate extended-release tablets. The order has an ultimate completion date of August 12, 2024. AmerisourceBergen is the prime contractor for this award, which is not set-aside. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This federal contract award is for the delivery of 4,566,528,747 units of Methylphenidate ER 18 mg tablets, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,827.88 firm fixed-price contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024 by the Defense Logistics Agency (DLA), a defense agency. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of 4,566,677,419 tablets of extended-release methylphenidate (40mg capsules) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $1,136.94 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,136.94 and will be performed in Conshohocken, PA, with a completion date of...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9CU
    Delivery Order

This federal contract award is for the delivery of 4,566,529,495 units of Methylphenidate Extended-Release (30mg capsules) to the Defense Logistics Agency (DLA). The $1,352.51 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 with a completion date of November 25, 2024.

The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/21/25, 10:00 AM